Cardamonin inhibits osteoclastogenesis induced by tumor cells throughinterruption of the signaling pathway activated by receptor activator of NF-κBligand.

Cancer Lett. 2011 Dec 17. [Epub ahead of print]

Cardamonin inhibits osteoclastogenesis induced by tumor cells throughinterruption of the signaling pathway activated by receptor activator of NF-κBligand.


Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.


This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause.
The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

Retraction Watch:

MD Anderson researcher Aggarwal loses paper in Cancer Letters

0 件のコメント: